Technology | April 08, 2008

Baxa Offers MedBoard Medication Tracking System


Baxa Corp. launched the MedBoard Web-based medication tracking system in December 2007, designed to record pharmacy preparation and delivery activities.

One of the first wireless tracking systems, MedBoard helps health systems improve productivity through order prioritization and delivery assurance, reducing time spent fielding nursing calls and tracking order status. With its order monitoring, MedBoard reportedly reduces waste by identifying time-sensitive orders and ensuring on-time delivery. Built-in reports allow pharmacy managers to demonstrate performance by delivery times, order type, nursing unit and more.

The MedBoard Medication Tracking System (MTS) is said to help pharmacies manage workflows using barcode technology, improving their efficiency and patient safety, by providing tracking for doses that are not part of pharmacy ADCs. The system requires a Web browser and hand-held scanners to get started. Once the user-customizable features have been determined, developers configure the hand-held devices to include the facility's specific rules, lists and users. MedBoard employs technical, administrative and policy safeguards to ensure data security, and is HIPAA compliant.

December 2007

Related Content

News | Pharmaceuticals

January 5, 2022 — The Feinstein Institutes for Medical Research, the science arm of Northwell Health, recently received ...

Home January 05, 2022
Home
News | Pharmaceuticals

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has cleared Novartis' inclisiran (Leqvio), the first small ...

Home January 04, 2022
Home
News | Pharmaceuticals

December 16, 2021 – Spanish pharmaceutical company Ferrer and the Spanish National Center for Cardiovascular Research ...

Home December 16, 2021
Home
Videos | Pharmaceuticals

Susan Cheng, M.D., MPH, director of the Institute for Research on Healthy Aging in the Department of Cardiology at ...

Home November 22, 2021
Home
News | Pharmaceuticals

November 19, 2021 — Results from two early clinical studies show the first version of an oral PCSK9-inhibitor ...

Home November 19, 2021
Home
News | Pharmaceuticals

November 15, 2021 — Esperion announced the presentation of three abstracts highlighting Nexletol tablets at the American ...

Home November 15, 2021
Home
News | Pharmaceuticals

November 15, 2021 — Novartis announced results from a pooled post-hoc analysis of Phase III ORION-9, -10 and -11 trials ...

Home November 15, 2021
Home
Feature | Pharmaceuticals | By Dave Fornell, DAIC Editor

There has been debate in recent years over balancing the risks vs. benefits of aspirin for the prevention of heart ...

Home October 13, 2021
Home
News | Pharmaceuticals

October 7, 2021 – The U.S. Food and Drug Administration (FDA) recently granted the breakthrough therapy designation for ...

Home October 07, 2021
Home
News | Pharmaceuticals

May 15, 2021 — A new analysis of the Phase 3 EXPLORER-HCM study evaluating mavacamten, an investigational, first-in ...

Home May 15, 2021
Home
Subscribe Now